{"DataElement":{"publicId":"6866989","version":"1","preferredName":"Colorectal Neuroendocrine Tumor AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for colon and rectal neuroendocrine tumor, using AJCC Ed. 8 criteria.","longName":"CRNET_AJC8_ DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6866958","version":"1","preferredName":"Colorectal Neuroendocrine Tumor Stage Grouping","preferredDefinition":"A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the colon or rectum._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6866944v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6866944","version":"1","preferredName":"Colorectal Neuroendocrine Tumor","preferredDefinition":"A well differentiated, low or intermediate grade tumor with neuroendocrine differentiation that arises from the colon or rectum.","longName":"C96159","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Neuroendocrine Tumor","conceptCode":"C96159","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the colon or rectum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"912D9C54-CE3B-168B-E053-F662850A2204","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"912EAC74-95E1-5BB0-E053-F662850A669A","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"TAYLORT","dateModified":"2020-12-14","changeDescription":"8-19-28 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6866925","version":"1","preferredName":"Colorectal Neuroendocrine Tumor American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of a colorectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to colorectal \"carcinoid\" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the colon and rectum are not staged using this staging system. (from AJCC 8th Ed.)_An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6866925v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Colorectal Neuroendocrine Tumor AJCC v8","ValueMeaning":{"publicId":"6866927","version":"1","preferredName":"Stage IV Colorectal Neuroendocrine Tumor AJCC v8","longName":"6866927","preferredDefinition":"Stage IV includes: (T1, Any N, M1); (T2, Any N, M1); (T3, Any N, M1); (T4, Any N, M1). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Colorectal Neuroendocrine Tumor AJCC v8","conceptCode":"C135211","definition":"Stage IV includes: (T1, Any N, M1); (T2, Any N, M1); (T3, Any N, M1); (T4, Any N, M1). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912B401D-9383-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"912B401D-939C-7012-E053-F662850A9F04","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8","ValueMeaning":{"publicId":"6866929","version":"1","preferredName":"Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8","longName":"6866929","preferredDefinition":"Stage IIIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N1, M0). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8","conceptCode":"C135210","definition":"Stage IIIB includes: (T1, N1, M0); (T2, N1, M0); (T3, N1, M0); (T4, N1, M0). T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912B401D-93A9-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"912B401D-93C2-7012-E053-F662850A9F04","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8","ValueMeaning":{"publicId":"6866931","version":"1","preferredName":"Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8","longName":"6866931","preferredDefinition":"Stage IIIA includes: T4, N0, M0. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8","conceptCode":"C135209","definition":"Stage IIIA includes: T4, N0, M0. T4: Tumor invading the visceral peritoneum (serosa) or other organs or adjacent structures. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912B401D-93CF-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"912B401D-93E8-7012-E053-F662850A9F04","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Colorectal Neuroendocrine Tumor AJCC v8","ValueMeaning":{"publicId":"6866933","version":"1","preferredName":"Stage IIB Colorectal Neuroendocrine Tumor AJCC v8","longName":"6866933","preferredDefinition":"Stage IIB includes: T3, N0, M0. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Colorectal Neuroendocrine Tumor AJCC v8","conceptCode":"C135208","definition":"Stage IIB includes: T3, N0, M0. T3: Tumor invading through the muscularis propria into subserosal tissue without penetration of overlying serosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912B401D-93F5-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"912B401D-940E-7012-E053-F662850A9F04","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Colorectal Neuroendocrine Tumor AJCC v8","ValueMeaning":{"publicId":"6866935","version":"1","preferredName":"Stage IIA Colorectal Neuroendocrine Tumor AJCC v8","longName":"6866935","preferredDefinition":"Stage IIA includes: T2, N0, M0. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Colorectal Neuroendocrine Tumor AJCC v8","conceptCode":"C135207","definition":"Stage IIA includes: T2, N0, M0. T2: Tumor invading the muscularis propria or measuring more than 2 cm with invasion of the lamina propria or submucosa. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912B401D-941B-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"912B401D-9434-7012-E053-F662850A9F04","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Colorectal Neuroendocrine Tumor AJCC v8","ValueMeaning":{"publicId":"6866937","version":"1","preferredName":"Stage I Colorectal Neuroendocrine Tumor AJCC v8","longName":"6866937","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Colorectal Neuroendocrine Tumor AJCC v8","conceptCode":"C135206","definition":"Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912B401D-9441-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"912B401D-945A-7012-E053-F662850A9F04","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6866924","version":"1","preferredName":"Colorectal Neuroendocrine Tumor by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of a colorectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to colorectal \"carcinoid\" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the colon and rectum are not staged using this staging system. (from AJCC 8th Ed.):An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C135205:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Neuroendocrine Tumor by AJCC v8 Stage","conceptCode":"C135205","definition":"A term that refers to the staging of a colorectal neuroendocrine tumor, following the rules of the TNM AJCC v8 classification system. This staging system applies to colorectal \"carcinoid\" tumors (neuroendocrine tumor G1 and G2, and rare-well differentiated G3). High-grade neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas of the colon and rectum are not staged using this staging system. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"912B401D-9356-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"ONEDATA","dateModified":"2019-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"912B401D-9367-7012-E053-F662850A9F04","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"TAYLORT","dateModified":"2020-12-14","changeDescription":"2020-12-14 TL released VD. 8-28-19 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000194","version":"1","longName":"Colorectal","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"913079D6-B64E-701E-E053-F662850A963C","latestVersionIndicator":"Yes","beginDate":"2019-08-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-08-28","modifiedBy":"TAYLORT","dateModified":"2020-12-14","changeDescription":"2020-12-14 TL released CDE. 8-28-19 TMT created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}